Literature DB >> 20802892

[Reasons for medical follow-up dropout among patients with arterial hypertension: the patient's perspective].

Marli Teresinha Cassamassimo Duarte1, Antonio Pithon Cyrino, Ana Teresa de Abreu Ramos Cerqueira, Maria Ines Battistella Nemes, Massako Iyda.   

Abstract

Arterial hypertension is a relevant public health problem as it is a risk factor for cardiovascular diseases, the major cause of mortality in Brazil. Low compliance and treatment dropout are among the main obstacles to individual control strategies. This study aimed at assessing the reasons for failure in medical appointment follow-up among a cohort of patients under treatment for four years in a primary care service. Thus, semi-structured interviews were conducted with 50 individuals who had dropped out of medical appointments. Statements were assessed by using thematic content analysis. The reported reasons for dropping out were most frequently related with the healthcare service itself - its organization and structure, and doctor-patient relationship - or treatment at another healthcare service. The reasons related with the patients themselves, such as absence of symptoms, improvement and/or normalization of arterial hypertension, as well as alcohol consumption contributed to the discontinuation of the treatment. To study the reasons for treatment dropout through the patients' eyes showed the abundance and diversity of problems involved.

Entities:  

Mesh:

Year:  2010        PMID: 20802892     DOI: 10.1590/s1413-81232010000500034

Source DB:  PubMed          Journal:  Cien Saude Colet        ISSN: 1413-8123


  2 in total

1.  Access to and use of high blood pressure medications in Brazil.

Authors:  Sotero Serrate Mengue; Andréa Dâmaso Bertoldi; Luiz Roberto Ramos; Mareni Rocha Farias; Maria Auxiliadora Oliveira; Noemia Urruth Leão Tavares; Paulo Sergio Dourado Arrais; Vera Lucia Luiza; Tatiane da Silva Dal Pizzol
Journal:  Rev Saude Publica       Date:  2016-12       Impact factor: 2.106

2.  Blood pressure control in hypertensive patients in the "Hiperdia Program": a territory-based study.

Authors:  Clarita Silva de Souza; Airton Tetelbom Stein; Gisele Alsina Nader Bastos; Lucia Campos Pellanda
Journal:  Arq Bras Cardiol       Date:  2014-06       Impact factor: 2.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.